Clinical trial
BiHiVE 2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.
NCT02019147 is registered in ClinicalTrials.gov with University College Cork as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BiHiVE 2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.
- Lead sponsor
- University College Cork
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- August 31, 2017
- Enrollment
- 500 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
asphyxia, hypoxic ischaemic encephalopathy (hie)